Cargando…
Systemic therapy for early-stage breast cancer: learning from the past to build the future
The treatment of breast cancer has improved dramatically over the past century, from a strictly surgical approach to a coordinated one, including local and systemic therapies. Systemic therapies for early-stage disease were initially tested against observation or placebo only in adjuvant trials. Sub...
Autores principales: | Agostinetto, Elisa, Gligorov, Joseph, Piccart, Martine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575647/ https://www.ncbi.nlm.nih.gov/pubmed/36253451 http://dx.doi.org/10.1038/s41571-022-00687-1 |
Ejemplares similares
-
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
por: Agostinetto, Elisa, et al.
Publicado: (2021) -
Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2023) -
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2022) -
Neoadjuvant treatment: the future of patients with breast cancer
por: Reyal, F, et al.
Publicado: (2018) -
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future
por: Gnecchi, Massimiliano
Publicado: (2018)